61 related articles for article (PubMed ID: 38475740)
1. MRTO4 Enhances Glycolysis to Facilitate HCC Progression by Inhibiting ALDOB.
Zheng Y; Huang Y; Li W; Cheng H
Med Sci Monit; 2024 May; 30():e944685. PubMed ID: 38778508
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of ribosome RNA processing protein 15 suppresses migration of hepatocellular carcinoma through inhibiting PATZ1-associated LAMC2/FAK pathway.
Pan T; Li J; Zhang O; Zhu Y; Zhou H; Ma M; Yu Y; Lyu J; Chen Y; Xu L
BMC Cancer; 2024 Mar; 24(1):334. PubMed ID: 38475740
[TBL] [Abstract][Full Text] [Related]
3. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X
J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532
[TBL] [Abstract][Full Text] [Related]
4. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
[TBL] [Abstract][Full Text] [Related]
5. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
Jin J; Liu H; Jin M; Li W; Xu H; Wei F
Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Ribosomal RNA Processing 15 Homolog (RRP15) Suppressed Tumor Growth, Invasion and Epithelial to Mesenchymal Transition (EMT) of Colon Cancer.
Deng Z; Xu Y; Cai Y; Lin W; Zhang L; Jiang A; Zhou Y; Zhao R; Zhao H; Liu Z; Yan T
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834940
[TBL] [Abstract][Full Text] [Related]
7. RRP15 deficiency induces ribosome stress to inhibit colorectal cancer proliferation and metastasis via LZTS2-mediated β-catenin suppression.
Dong Z; Li J; Dai W; Yu D; Zhao Y; Liu S; Li X; Zhang Z; Zhang R; Liang X; Kong Q; Jin S; Jiang H; Jiang W; Ding C
Cell Death Dis; 2023 Feb; 14(2):89. PubMed ID: 36750557
[TBL] [Abstract][Full Text] [Related]
8. Validating RRP12 Expression and Its Prognostic Significance in HCC Based on Data Mining and Bioinformatics Methods.
Wei C; Wang B; Chen ZH; Xiao H; Tang L; Guan JF; Yuan RF; Yu X; Hu ZG; Wu HJ; Dai Z; Wang K
Front Oncol; 2022; 12():812009. PubMed ID: 35178347
[TBL] [Abstract][Full Text] [Related]
9. Novel LAMC2 fusion protein has tumor-promoting properties in ovarian carcinoma.
Daisuke H; Kato H; Fukumura K; Mayeda A; Miyagi Y; Seiki M; Koshikawa N
Cancer Sci; 2021 Dec; 112(12):4957-4967. PubMed ID: 34689384
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ribosomal RNA processing 15 Homolog (RRP15), which is overexpressed in hepatocellular carcinoma, suppresses tumour growth via induction of senescence and apoptosis.
Zhao D; Qian L; Zhuang D; Wang L; Cao Y; Zhou F; Zhang S; Liu Y; Liang Y; Zhang W; Kang W; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Xu G; Lv Y; Zou X; Zhuge Y; Zhang B
Cancer Lett; 2021 Oct; 519():315-327. PubMed ID: 34343634
[TBL] [Abstract][Full Text] [Related]
11. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
